Pay in 4 interest-free payments of $6.36 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Often known by the brand names Ozempic and Wegovy, this medication belongs to a class of drugs called GLP-1 receptor agonists
The ability to track trends over weeks and months reveals patterns that single point measurements miss
In some people, these medications slow the stomach too much, which can cause food to stay in the stomach longer and lead to nausea, vomiting, bloating and pain
No, GLP-1 patches do not contain GLP-1 and neither do FDA-approved GLP-1 medications, for that matter
As a result, coverage of GLP-1 drugs for the treatment of obesity remains optional for states, while coverage is required for drugs approved for the treatment of diabetes and, since March 2024 and December 2024, for the treatment of cardiovascular disease (Wegovy) and moderate to severe obstructive sleep apnea in adults with obesity (Zepbound), respectively (Table 1)
GLP-1 Use by Indication This means that gender differences appear strongest in weight-loss-driven use, not diabetes care
